G Ruiz-Irastorza and MA Khamashta

Hydroxychloroquine: the cornerstone of lupus therapy
Lupus 2008 17: 271-273. [PDF] [References]  

J Pope

An update in pulmonary hypertension in systemic lupus erythematosus – do we need to know about it?
Lupus 2008 17: 274-277. [Abstract] [PDF] [References]  

M Mosca, C Tani, and S Bombardieri

Defining undifferentiated connective tissue diseases: a challenge for rheumatologists
Lupus 2008 17: 278-280. [PDF] [References]  

A Sisó, M Ramos-Casals, A Bové, P Brito-Zerón, N Soria, S Muñoz, A Testi, J Plaza, J Sentís, and A Coca

Previous antimalarial therapy in patients diagnosed with lupus nephritis: Influence on outcomes and survival
Lupus 2008 17: 281-288. [Abstract] [PDF] [References]  

MI Vargas-Rojas, JC Crispín, Y Richaud-Patin, and J Alcocer-Varela

Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance
Lupus 2008 17: 289-294. [Abstract] [PDF] [References]  

J Rojas-Serrano, J Pedroza, J Regalado, J Robledo, E Reyes, J Sifuentes-Osornio, and LF Flores-Suárez

High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage
Lupus 2008 17: 295-299. [Abstract] [PDF] [References]  

GN Damián-Abrego, J Cabiedes, and AR Cabral

Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy
Lupus 2008 17: 300-304. [Abstract] [PDF] [References]  

SL Lui, S Yung, R Tsang, F Zhang, KW Chan, S Tam, and TM Chan

Rapamycin prevents the development of nephritis in lupus-prone NZB/W F₁ mice
Lupus 2008 17: 305-313. [Abstract] [PDF] [References]  

LB Tucker, AG Uribe, M Fernández, LM Vilá, G McGwin, M Apte, BJ Fessler, HM Bastian, JD Reveille, and GS Alarcón

Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case–control study within LUMINA, a multiethnic US cohort (LUMINA LVII)
Lupus 2008 17: 314-322. [Abstract] [PDF] [References]  

X Lu, Y Gu, Y Wang, S Chen, and S Ye

Prognostic factors of lupus myelopathy
Lupus 2008 17: 323-328. [Abstract] [PDF] [References]  

AV Marzano, S Ramoni, N Del Papa, M Barbareschi, and E Alessi

Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions
Lupus 2008 17: 329-331. [Abstract] [PDF] [References]  

AM Katramados, R Rabah, MD Adams, AHMM Huq, and PD Mitsias

Longitudinal myelitis, aseptic meningitis, and conus medullaris infarction as presenting manifestations of pediatric sysemic lupus erythematosus
Lupus 2008 17: 332-336. [Abstract] [PDF] [References]  

S Koskenmies, TM Järvinen, P Onkamo, J Panelius, U Tuovinen, T Hasan, A Ranki, and U Saarialho-Kere

Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations
Lupus 2008 17: 337-347. [Abstract] [PDF] [References]  

AM Negrón, MJ Molina, AM Mayor, VE Rodríguez, and LM Vilá

Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico
Lupus 2008 17: 348-354. [Abstract] [PDF] [References]  

JL Callejas-Rubio, L López-Pérez, E Moreno-Escobar, and N Ortego-Centeno

Raynaud's phenomenon and pulmonary arterial hypertension
Lupus 2008 17: 355. [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.